Streetbeat News

Products Services

NEWT

PALT

Paltalk, Inc. (NASDAQ:PALT) has entered into a definitive agreement to acquire Newtek Technology Solutions, Inc. from NewtekOne, Inc. (NASDAQ:NEWT) for $4 million in cash and 4 million shares of a newly created series of Paltalk's preferred stock. The acquisition will enhance Paltalk's offerings in server hosting, cloud hosting, data storage, and managed security services.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:08 pm

AMLX

Amylyx Pharmaceuticals announced the publication of data from the Phase 2 PEGASUS trial, showing that their drug AMX0035 affects cerebrospinal fluid biomarkers related to Alzheimer's disease and neurodegeneration. The findings were published in the journal Alzheimer's & Dementia: Translational Research & Clinical Interventions.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:06 pm

TDC

Teradata (NYSE:TDC) has been named the official cloud analytics partner for the Los Angeles Clippers and their new arena, Intuit Dome. The partnership includes leveraging Teradata VantageCloud Lake and AI technologies. Teradata is also a Founding Partner of Intuit Dome with special entitlement of the arena's Halo Loft Level.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:05 pm

CYTO

Altamira Therapeutics' Zbtb46 mRNA nanoparticles have shown significant tumor growth reduction and long-term remission when combined with anti-PD1 therapy, according to results published in Nature Immunology. This highlights the potential to enhance the effectiveness of immune checkpoint inhibitors.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:04 pm

HOOD

Robinhood has appointed Jeff Pinner as its new Chief Technology Officer. Pinner brings extensive experience from his previous roles at Twitter and Google, which is expected to bolster Robinhood's technological capabilities.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:03 pm

PRFX

PainReform Ltd. (NASDAQ:PRFX) has announced the successful development and manufacturing of new patented formulations of its extended postoperative pain relief therapy, PRF-110. These formulations incorporate both an analgesic and an anti-inflammatory agent, designed to enhance postoperative recovery and reduce opioid reliance.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:03 pm

SCPH

scPharmaceuticals Inc. (NASDAQ:SCPH) received FDA approval for expanded use of Furoscix to include NYHA Class IV heart failure patients. The company also secured $125 million in non-dilutive financing to support commercialization efforts and released positive topline results from a pharmacokinetic study of SCP-111. Additionally, scPharmaceuticals announced a proposed public offering of shares and pre-funded warrants.

Portfolio Pulse from Vandana Singh

August 12, 2024 | 1:02 pm

FXI

NVDA

The Information reports that smuggling of Nvidia's AI chips to China has become an industry. This could have significant implications for Nvidia's stock and the broader market, including ETFs like FXI that have exposure to Chinese tech companies.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:02 pm

LIQT

LiqTech International has received an order from a leading energy company to deliver a pilot system for produced water treatment in the U.S. The company aims to develop commercial systems for onshore oil and gas applications.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:01 pm

INTA

MSFT

Intapp has launched Intapp Assist for Terms, a generative AI feature that provides immediate answers to client contractual questions within Microsoft Teams.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:00 pm